The Pharma Contract Sales Market Report 2021-2031: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Inclination Of Pharma Companies Towards Contract Sales To Gain A Competitive Edge
The pharma services industry is consolidating as companies aim to gain a competitive edge over their competitors by increasing size, expanding geographical reach, and achieving synergies. Recent M&A in the sub-sector motivated by pharma's desire to work with less outsourced service providers, as well as a desire to consolidate but also broaden service portfolios outside of conventional CSO services into complementary adjacent fields. Ashfield's entrance into the commercialisation consulting and marketing industries is an example of this.
The Pharma Contract Sales Is All-In-One Solution
Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers' operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use. For example, The Apodi Healthcare is providing wide range of solutions such as for human-centred, requiring the deployment of promotional resources and/or healthcare professionals, and are often aided by cutting-edge technology. Their services are mainly focused on educating and promoting particular drugs to healthcare professionals, as well as providing patient programmes that help their strategies make a real difference by improving patients' lives, funding the NHS, and generating revenue for their clients.
What Are These Questions You Should Ask Before Buying A Market Research Report?
• How is the pharma contract sales market evolving?
• What is driving and restraining the pharma contract sales market?
• How will each pharma contract sales submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2031?
• How will the market shares for each pharma contract sales submarket develop from 2021 to 2031?
• What will be the main driver for the overall market from 2021 to 2031?
• Will leading pharma contract sales markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2031 and which geographical region will lead the market in 2031?
• Who are the leading players and what are their prospects over the forecast period?
• What are the pharma contract sales projects for these leading companies?
• How will the industry evolve during the period between 2019 and 2031?What are the implication of pharma contract sales projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the pharma contract sales market?
• Where is the pharma contract sales market heading? And how can you ensure you are at the forefront of the market?
• What can be the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path? C-suite?
You need to discover how this will impact the pharma contract sales market today, and over the next 10 years:
• Our 522-page report provides 331 tables and 311 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• Contains in-depth analyse of global, regional and national sales and growth
• Highlights for you the key successful trends, changes and revenue projections made by your competitors
This report tells you TODAY how the pharma contract sales market will develop in the next 10 years, and in-line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising pharma contract sales prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, V, L, W and U are discussed in this report.
Global Pharma Contract Sales Market (COVID Impact Analysis) by Type
• Personal Promotion
• Non-Personal Promotion
• Co-Promotion
Global Pharma Contract Sales Market (COVID Impact Analysis) by Personal Promotion
• Standard Field Force Roles
• Sales Deployment
• Vacancy Coverage
• HCP Educational Programs
• Key Account Management
• Other Personal Promotion Services
Global Pharma Contract Sales Market (COVID Impact Analysis) by Non-Personal Promotion
• Contact Center
• Teledetailing
• Medical Call Centers
• Telesampling
• Online Services
Global Pharma Contract Sales Market (COVID Impact Analysis) by Co-Promotion
• Marketing Research and Consulting
• Product Commercialization
• Territory Optimization & Alignment
• Brand Management
• Mature Product Line Support
• Rest All CSO Services
Global Pharma Contract Sales Market (COVID Impact Analysis) by Therapeutic
• Cardiovascular Disease
• Metabolic Disorders
• Oncology
• Alzheimer's Disease
• Diabetes
• Other Therapeutics
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 4 regional and 20 leading national markets:
• North America Pharma Contract Sales Market, 2021 to 2031 Market Outlook
• U.S. Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Canada Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Mexico Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Europe Pharma Contract Sales Market, 2021 to 2031 Market Outlook
• Germany Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Spain Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• United Kingdom Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• France Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Italy Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Rest of Europe Market Forecast & COVID Impact Analysis
• Asia Pacific Pharma Contract Sales Market, 2021 to 2031 Market Outlook
• China Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Japan Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• India Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Australia Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• South Korea Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Rest of Asia Pacific Market Forecast & COVID Impact Analysis
• LAMEA Pharma Contract Sales Market, 2021 to 2031 Market Outlook
• Brazil Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Turkey Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Saudi Arabia Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• South Africa Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• UAE Pharma Contract Sales Market, 2021 to 2031 Market Forecast & COVID Impact Analysis
• Rest of Latin America, Middle East and Africa
The report also includes profiles and for some of the leading companies in the Pharma Contract Sales Market, 2021 to 2031, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth:
• Amplity Health
• Apodi Healthcare Limited
• CMIC Holdings Co., Ltd
• Granard Pharmaceuticals
• GTS Solution
• IQVIA Holdings Inc.
• MaBiCo (Contract Sales Organization)
• Marvecs GmbH
• OnCall LLC
• Publicis Groupe SA
• QFR Solutions
• Sales Partnerships Inc.
• Sofip
• Syneos Health Inc.
• UDG Healthcare PLC
• Vanguard Pharma
Overall world revenue for Pharma Contract Sales Market, 2021 to 2031 in terms of value the market will surpass US$xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Pharma Contract Sales Market, 2021 to 2031 Market report helps you?
In summary, our 520+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Pharma Contract Sales Market, 2021 to 2031 Market, with forecasts for type, Personal Promotion, Non-Personal Promotion, Co-Promotion, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 4 regional and 20 key national markets – See forecasts for the Pharma Contract Sales Market, 2021 to 2031 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 16 of the major companies involved in the Pharma Contract Sales Market, 2021 to 2031 Market.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Pharma Contract Sales Market, 2021 to 2031 Market and leading companies. You will find data, trends and predictions.
'
1. Report Overview
1.1 Introduction to Pharma Contract Sales Market
1.2 Global Pharma Contract Sales Market Overview
1.3 What are the Objectives of this Report?
1.4 What is the Scope of the Report?
1.5 Pharma Contract Sales Market Definition
1.6 Why You Should Read This Report
1.7 What This Report Delivers
1.8 Key Questions Answered By This Analytical Report Include:
1.9 Who is This Report for?
1.10 Research Methodology
1.10.1 Primary Research
1.10.2 Secondary Research
1.10.3 Market Evaluation & Forecasting Methodology
1.11 Frequently Asked Questions (FAQs)
1.12 Associated Reports
1.13 About
2 Executive Summary
3 Pharma Contract Sales Industry Structure
3.1 Overview
3.2 Outsource Pharma Services
3.2.1 Contract Development and Manufacturing Organisations (CDMOs)
3.2.2 Contract Packaging Organisations (CPOs)
3.2.3 Contract Sales Organisations (CSOs)
3.2.4 Serialisation
3.2.5 Contract Research Organisations (CROs)
3.2.6 Contract Development and Manufacturing Organisations (CDMOs)
4 Global Market Dynamics
4.1 Market Driving Factors
4.1.1 Extension Of The Platform
4.1.2 Expertise Shift To Outsourcers
4.1.3 Increased Technological Utilisation
4.2 Market Restraining Factors
4.2.1 Drugs And Clinical Trials Are Becoming More Complex.
4.2.2 Quality Compromise In Pharma Sales Services
4.2.3 Restricts Growth Of The Submarket Of Contract Pharma Sakes API
4.3 Opportunities in the Global Market
4.3.1 Outsourcing Is Becoming More Common Due to Pressures from The Pharmaceutical Industry.
4.3.2 The Pharma Contract Sales Is "All-In-One" Solution
4.3.3 Increased Interest In CRO Services Fuelled By Data
4.4 Challenges in the Global Market
4.4.1 The Need Of Reducing R&D Spending
4.4.2 More Expensive Treatments In The Process
4.4.3 Market Evaluation Challenges: Supply Vs Demand Market
4.5 SWOT Analysis
4.5.1 Strengths
4.5.2 Weakness
4.5.3 Opportunities
4.5.4 Threats
4.6 PEST Analysis
4.6.1 Political
4.6.2 Economical
4.6.3 Sociocultural
4.6.4 Technology
4.7 Porter Five Forces
4.7.1 What is Porter Five (5) Forces
4.7.2 Threat of New Entrants (Low to Moderate)
4.7.3 Rivalry Among the Existing Players (High)
4.7.4 Bargaining Power of Suppliers (Low)
4.7.5 Threats from Substitute Products (Low to Moderate)
4.7.6 Bargaining Power of Buyers (High)
5 Global Pharma Contract Sales Market Analysis
5.1 Global Market Outlook
5.2 Global Market Size Estimation and Forecast
5.2.1 Pre-COVID-19 Market Scenario
5.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
5.3 Regional Market Size Estimation and Forecast
5.3.1 Pre-COVID-19 Market Scenario
5.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
6 Global Market Size Estimation and Forecast By Type
6.1 Segment Overview
6.1.1 Personal Promotion
6.1.2 Non-Personal Promotion
6.1.3 Co-Promotion
6.2 Pre-COVID-19 Market Scenario
6.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
7 Global Market Size Estimation and Forecast By Personal Promotion
7.1 Commercial Aspects
7.2 Segment Overview
7.2.1 Standard Field Force Roles
7.2.2 Sales Deployment
7.2.3 Vacancy Coverage
7.2.4 Health Care Professional Educational Programs
7.2.5 Key Account Management
7.3 Pre-COVID-19 Market Scenario
7.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
8 Global Market Size Estimation and Forecast By Non- Personal Promotion
8.1 Commercial Aspects
8.2 Segment Overview
8.2.1 Contact Center
8.2.2 Teledetailing
8.2.3 Medical Call Centers
8.2.4 Telesampling
8.2.5 Online Services
8.3 Pre-COVID-19 Market Scenario
8.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
9 Global Market Size Estimation and Forecast By Co-Promotion
9.1 Commercial Aspects
9.2 Segment Overview
9.2.1 Marketing Research and Consulting
9.2.2 Territory Optimization & Alignment
9.2.3 Brand Management
9.2.4 Mature Product Line Support
9.3 Pre-COVID-19 Market Scenario
9.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10 Global Market Size Estimation and Forecast By Therapeutic
10.1 Commercial Aspects
10.2 Segment Overview
10.2.1 Cardiovascular Disease
10.2.2 Metabolic Disorders
10.2.3 Oncology
10.2.4 Alzheimer's Disease
10.2.5 Diabetes
10.3 Pre-COVID-19 Market Scenario
10.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11 North America Market Size Estimation and Forecast
11.1 North America Market Size Estimation and Forecast
11.1.1 Changing Pharmaceutical And Health Industry Dynamics Led To Innovation in the North America Region
11.1.2 Pre-COVID-19 Market Scenario
11.1.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.2 Country Market Size Estimation and Forecast
11.2.1 Pre-COVID-19 Market Scenario
11.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.3 North America Market Size Estimation and Forecast By Type
11.3.1 Pre-COVID-19 Market Scenario
11.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.4 North America Market Size Estimation and Forecast By Personal Promotion
11.4.1 Pre-COVID-19 Market Scenario
11.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.5 North America Market Size Estimation and Forecast By Non- Personal Promotion
11.5.1 Pre-COVID-19 Market Scenario
11.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.6 North America Market Size Estimation and Forecast By Co-Promotion
11.6.1 Pre-COVID-19 Market Scenario
11.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.7 North America Market Size Estimation and Forecast By Therapeutic
11.7.1 Pre-COVID-19 Market Scenario
11.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.8 U.S. Market Analysis
11.8.1 The US is One of the Most Important Pharmaceutical Markets Due to Presence of Largest Pharmaceutical Firms
11.8.2 U.S. Regulations Regarding Contract Sales
11.8.3 Pre-COVID-19 Market Scenario
11.8.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.9 Canada Market Analysis
11.9.1 Canada Market Consists Of A Variety Of Sub-Sectors Serving Various Segments Of The Industry
11.9.2 Pharma Sales Are Scattered Among Toronto, Montreal And Vancouver Metropolitan Areas
11.9.3 Pre-COVID-19 Market Scenario
11.9.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11.10 Mexico Market Analysis
11.10.1 Mexico With Over 350 Local And Cross-Border Businesses Producing Pharmaceuticals Influence US Market
11.10.2 Pre-COVID-19 Market Scenario
11.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12 Asia-Pacific Market Size Estimation and Forecast
12.1 Asia-Pacific Market Size Estimation and Forecast
12.1.1 The Rise Of Pharma Contract Sales Organisations In The APAC Is Guided By The Changing Market Access, Repayment Policies And Competitive Environment
12.1.2 In Pharmaceutical Investment In The World, Asia Is The Fastest Expanding Region
12.1.3 Pre-COVID-19 Market Scenario
12.1.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.2 Country Market Size Estimation and Forecast
12.2.1 Pre-COVID-19 Market Scenario
12.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.3 Asia-Pacific Market Size Estimation and Forecast By Type
12.3.1 Pre-COVID-19 Market Scenario
12.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.4 Asia-Pacific Market Size Estimation and Forecast By Personal Promotion
12.4.1 Pre-COVID-19 Market Scenario
12.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.5 Asia-Pacific Market Size Estimation and Forecast By Non- Personal Promotion
12.5.1 Pre-COVID-19 Market Scenario
12.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.6 Asia-Pacific Market Size Estimation and Forecast By Co-Promotion
12.6.1 Pre-COVID-19 Market Scenario
12.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.7 Asia-Pacific Market Size Estimation and Forecast By Therapeutic
12.7.1 Pre-COVID-19 Market Scenario
12.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.8 China Market Analysis
12.8.1 Ever Growing Pharma Industry in China
12.8.2 Driving Element Behind The Tremendous Outsourcing Growth Of China
12.9 Pre-COVID-19 Market Scenario
12.9.1 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.10 India Market Analysis
12.10.1 Strong Foothold of Pharma Companies In India
12.10.2 Evolving Healthcare System in the Country
12.10.3 Pre-COVID-19 Market Scenario
12.10.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.11 Japan Market Analysis
12.11.1 Steady Pharma Growth and Development In Japan Will Drive Contract Sales Market
12.11.2 Pool of Opportunities in Japan for CSOs
12.11.3 Pre-COVID-19 Market Scenario
12.11.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.12 South Korea Market Analysis
12.12.1 South Korea Hopes To Win 6% Of Global Pharmaceutical And Medical Device Manufacturing By 2030
12.12.2 Pre-COVID-19 Market Scenario
12.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.13 Australia Market Analysis
12.13.1 Pharmaceutical Market In Australia Represents A Knowledge-Based, Technology-Intensive Industry
12.13.2 Number Of Opportunities Open To Companies Hoping To Invest In The Australian Pharmaceutical Industry
12.13.3 Pre-COVID-19 Market Scenario
12.13.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.14 Rest of Asia-Pacific Market Analysis
12.14.1 More Launches, Increased Payer and Regulatory Scrutiny, And Increased Rivalry Have Resulted In Shorter Sales Cycles In Asia-Pacific
12.14.2 Pre-COVID-19 Market Scenario
12.14.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13 Europe Market Size Estimation and Forecast
13.1 Region Overview
13.1.1 Outsourced Products Have Grown Beyond Their Original Focus And Now Address A Wide Range Of Company Demands
13.1.2 Europe Is Emerging As Competitive Sources Of Contract Production And Sales Services
13.1.3 Growing Presence of Contract Sales development and manufacturing (CDMOs) companies
13.2 Europe Market Size Estimation and Forecast
13.2.1 Pre-COVID-19 Market Scenario
13.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.3 Country Market Size Estimation and Forecast
13.3.1 Pre-COVID-19 Market Scenario
13.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.4 Europe Market Size Estimation and Forecast By Type
13.4.1 Pre-COVID-19 Market Scenario
13.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.5 Europe Market Size Estimation and Forecast By Personal Promotion
13.5.1 Pre-COVID-19 Market Scenario
13.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.6 Europe Market Size Estimation and Forecast By Non- Personal Promotion
13.6.1 Pre-COVID-19 Market Scenario
13.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.7 Europe Market Size Estimation and Forecast By Co-Promotion
13.7.1 Pre-COVID-19 Market Scenario
13.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.8 Europe Market Size Estimation and Forecast By Therapeutic
13.8.1 Pre-COVID-19 Market Scenario
13.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.9 Germany Market Analysis
13.9.1 Germany Is The World's Largest Market For Biosimilar Pharmaceuticals Creates Opportunities for CSOs
13.9.2 Pre-COVID-19 Market Scenario
13.9.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.10 UK Market Analysis
13.10.1 Challenges in the UK Pharmaceutical Market
13.10.2 Pre-COVID-19 Market Scenario
13.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.11 France Market Analysis
13.11.1 France Is Europe's Third-Largest Market And One Of The Biggest Pharmaceutical Users In The World
13.11.2 Not Every Pharmaceutical Company Prefers Contract Sales In France
13.11.3 Pre-COVID-19 Market Scenario
13.11.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.12 Italy Market Analysis
13.12.1 Pharma Contract Sales Is One of the Important Pharma Segment in Italy
13.12.2 Pre-COVID-19 Market Scenario
13.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.13 Spain Market Analysis
13.13.1 Spain's Pharmaceutical Industry Has Always Been One Of Spain's Main Pillars In High-Tech Production.
13.13.2 Pre-COVID-19 Market Scenario
13.13.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.14 Rest of Europe Market Analysis
13.14.1 Outsourcing Has Increased Significantly In Rest Of Europe
13.14.2 Pre-COVID-19 Market Scenario
13.14.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14 LAMEA Market Size Estimation and Forecast
14.1 Regional Overview
14.1.1 Lack Of Substantial Expertise And Costly Capabilities Are Main Challenges In The Region
14.1.2 The Outbreak Of Coronavirus Has A Significant Effect On Third-Party Service Providers In Biotech And Pharmaceuticals
14.2 LAMEA Market Size Estimation and Forecast
14.2.1 Pre-COVID-19 Market Scenario
14.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.3 Country Market Size Estimation and Forecast
14.3.1 Pre-COVID-19 Market Scenario
14.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.4 LAMEA Market Size Estimation and Forecast By Type
14.4.1 Pre-COVID-19 Market Scenario
14.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.5 LAMEA Market Size Estimation and Forecast By Personal Promotion
14.5.1 Pre-COVID-19 Market Scenario
14.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.6 LAMEA Market Size Estimation and Forecast By Non- Personal Promotion
14.6.1 Pre-COVID-19 Market Scenario
14.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.7 LAMEA Market Size Estimation and Forecast By Co-Promotion
14.7.1 Pre-COVID-19 Market Scenario
14.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.8 LAMEA Market Size Estimation and Forecast By Therapeutic
14.8.1 Pre-COVID-19 Market Scenario
14.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.9 Brazil Market Analysis
14.9.1 Brazil Is The Only Latin American Country To Be Ranked Among The World's Top Pharmaceutical Markets
14.9.2 Pre-COVID-19 Market Scenario
14.9.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.10 South Africa Market Analysis
14.10.1 The Pharmaceutical Market In South Africa Is The Biggest In Africa
14.10.2 Pre-COVID-19 Market Scenario
14.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.11 Saudi Arabia Market Analysis
14.11.1 Saudi Arabia is one of the most appealing markets in Middle East For Pharma Products
14.11.2 Pre-COVID-19 Market Scenario
14.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.12 Turkey Market Analysis
14.12.1 Government Initiative To Limit Importations And Boost The Local Production Of The Pharmaceutical Industries In Turkey
14.12.2 Pre-COVID-19 Market Scenario
14.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.13 UAE Market Analysis
14.13.1 The UAE Governments Are Also Focused On Minimising Their Reliance On Imported Pharmaceuticals
14.13.2 Pre-COVID-19 Market Scenario
14.13.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.14 Rest of LAMEA Market Analysis
14.14.1 The Value Of Commercial Outsourcing Becomes Apparent In The Pharmaceutical Business In LAMEA
14.14.2 Pre-COVID-19 Market Scenario
14.14.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15 Competitive Landscape
15.1 Company Market Share Analysis
15.2 Key Business Strategy Analysis
15.3 New Product/Service Launch as the Key Business Strategy In the Global Market
15.4 Acquisition as the Key Business Strategy In the Global Market
15.5 Partnership as the Key Business Strategy In the Global Market
15.6 Collaboration as the Key Business Strategy In the Global Market
15.7 Expansion as the Key Business Strategy In the Global Market
15.8 Agreement as the Key Business Strategy In the Global Market
15.9 Contract as the Key Business Strategy In the Global Market
16 Leading Company Profiles
16.1 Apodi Healthcare Limited
16.1.1 Company Snapshot
16.1.2 Company Overview
16.1.3 Company Product Benchmarking
16.2 CMIC Holdings Co., Ltd
16.2.1 Company Snapshot
16.2.2 Company Overview
16.2.3 Company Financial Profile
16.2.4 Company Product Benchmarking
16.2.5 Company Recent Developments
16.3 Syneos Health Inc.
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Company Financial Profile
16.3.4 Company Product Benchmarking
16.3.5 Company Recent Developments
16.4 IQVIA Holdings Inc.
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Company Financial Profile
16.4.4 Company Product Benchmarking
16.4.5 Company Recent Developments
16.5 Marvecs GmbH
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Company Product Benchmarking
16.6 OnCall LLC
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Company Product Benchmarking
16.7 Publicis Groupe SA
16.7.1 Company Snapshot
16.7.2 Company Overview
16.7.3 Company Financial Profile
16.7.4 Company Product Benchmarking
16.7.5 Company Recent Developments
16.8 Sofip
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Company Product Benchmarking
16.9 UDG Healthcare PLC
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Company Financial Profile
16.9.4 Company Product Benchmarking
16.9.5 Company Recent Developments
16.10 Amplity Health
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Company Product Benchmarking
16.10.4 Company Recent Developments
16.11 Granard Pharmaceuticals
16.11.1 Company Snapshot
16.11.2 Company Overview
16.11.3 Company Product Benchmarking
16.12 Vanguard Pharma
16.12.1 Company Snapshot
16.12.2 Company Overview
16.12.3 Company Product Benchmarking
16.13 GTS Solution
16.13.1 Company Snapshot
16.13.2 Company Overview
16.13.3 Company Product Benchmarking
16.14 MaBiCo (Contract Sales Organization)
16.14.1 Company Snapshot
16.14.2 Company Overview
16.14.3 Company Product Benchmarking
16.15 Sales Partnerships Inc.
16.15.1 Company Snapshot
16.15.2 Company Overview
16.15.3 Company Product Benchmarking
16.16 QFR Solutions
16.16.1 Company Snapshot
16.16.2 Company Overview
16.16.3 Company Product Benchmarking
17 Conclusion and Recommendations
17.1 Concluding Remarks
17.2 Recommendations
18 Glossary Terms
18.1 List Of Other Notable Player
18.2 List of Organization
List of Tables
Table 1. Global Pharma Contract Sales Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 2. Global Pharma Contract Sales Market Snapshot, 2021 & 2031 (US$million, CAGR %)
Table 3. Global Pharma Contract Sales Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 4. Global Pharma Contract Sales Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 5. Global Pharma Contract Sales Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 6. Global Pharma Contract Sales Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 7. Global Pharma Contract Sales Market Forecast, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 8. Global Pharma Contract Sales Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 9. Global Pharma Contract Sales Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 10. Global Pharma Contract Sales Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 11. Global Pharma Contract Sales Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 12. Global Pharma Contract Sales Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 13. Global Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 14. Global Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 15. Global Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 16. Global Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 17. Global Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 18. Global Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 19. Global Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 20. Global Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 21. Global Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 22. Global Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 23. Global Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 24. Global Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 25. Global Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 26. Global Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 27. Global Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 28. Global Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 29. Global Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 30. Global Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 31. Global Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 32. Global Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 33. Global Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 34. Global Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 35. Global Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 36. Global Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 37. Global Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 38. North America Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 39. North America Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 40. North America Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 41. North America Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 42. North America Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 43. North America Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 44. North America Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shaped Recovery)
Table 45. North America Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shaped Recovery)
Table 46. North America Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shaped Recovery)
Table 47. North America Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shaped Recovery)
Table 48. North America Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 49. North America Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 50. North America Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 51. North America Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 52. North America Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 53. North America Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 54. North America Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 55. North America Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 56. North America Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 57. North America Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 58. North America Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 59. North America Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 60. North America Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 61. North America Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 62. North America Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 63. North America Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 64. North America Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 65. North America Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 66. North America Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 67. North America Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 68. North America Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 69. North America Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 70. North America Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 71. North America Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 72. North America Pharma Contract Sales Market by Therapeutic, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 73. U.S. Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 74. U.S. Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 75. U.S. Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 76. U.S. Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 77. U.S. Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 78. Canada Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 79. Canada Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 80. Canada Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 81. Canada Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 82. Mexico Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 83. Mexico Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 84. Mexico Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 85. Mexico Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 86. Asia-Pacific Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 87. Asia-Pacific Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 88. Asia-Pacific Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 89. Asia-Pacific Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 90. Asia-Pacific Pharma Contract Sales Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 91. Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 92. Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 93. Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 94. Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 95. Asia-Pacific Pharma Contract Sales Market by Country, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 96. Asia-Pacific Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 97. Asia-Pacific Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 98. Asia-Pacific Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 99. Asia-Pacific Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 100. Asia-Pacific Pharma Contract Sales Market by Type, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 101. Asia-Pacific Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 102. Asia-Pacific Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 103. Asia-Pacific Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 104. Asia-Pacific Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 105. Asia-Pacific Pharma Contract Sales Market by Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 106. Asia-Pacific Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 107. Asia-Pacific Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 108. Asia-Pacific Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 109. Asia-Pacific Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 110. Asia-Pacific Pharma Contract Sales Market by Non-Personal Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(L-Shape Recovery)
Table 111. Asia-Pacific Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))
Table 112. Asia-Pacific Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(V-Shape Recovery)
Table 113. Asia-Pacific Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(W-Shape Recovery)
Table 114. Asia-Pacific Pharma Contract Sales Market by Co-Promotion, 2021-2031 (USD Mn, AGR (%), CAGR(%))(U-Shape Recovery)
Table 115. Asia-Pacific Pharma Cont
